US Earnings Financial Results SEC Filings — May 20, 2026

20-05-2026

Haemonetics Corp reported a 2.0% decline in net revenues to $1,334,027K for fiscal year 2026, with a significant 42.0% drop in net income to $97,308K compared to $167,679K in FY2025. While gross profit improved 5.2% to $787,586K and gross margin expanded to 59.0% from 55.0%, operating income fell 29.3% to $156,734K due to a 19.7% increase in operating expenses, driven by a $86,546K impairment of intangible assets. Segment performance was mixed: Hospital net revenues grew 4.3% (led by Blood Management Technologies +14.6%), but Plasma revenues declined 2.0% and Blood Center revenues fell 15.3% (Whole Blood -99.2%).

• · Net debt position worsened to $979,140K from $918,025K in FY2025.
• · Working capital improved to $552,280K from $356,862K, and current ratio increased to 3.0 from 1.6.
• · Days sales outstanding remained stable at 56 days vs 55 days.
• · Inventory turnover improved slightly to 1.5 from 1.4.
• · Net cash used in investing activities increased to $179,547K from $161,895K.
• · Financing activities swung to a net use of $178,460K from a net source of $108,818K.
• · US revenue declined 2.8% (reported) while International revenue grew 0.6% (reported), but constant currency growth was negative for both (US -2.8%, International -2.6%).
• · Revenue mix shifted: US share decreased to 73.6% from 74.3%, Europe increased to 13.9% from 12.9%, Japan increased to 5.1% from 4.6%.
• · SG&A expense as a percentage of net revenues increased to 33.2% from 32.1%.
• · R&D expense as a percentage of net revenues decreased slightly to 4.5% from 4.6%.

20-05-2026

Analog Devices Inc. (ADI) reported a strong Q2 FY2026 with revenue of $3.62B, up 37% YoY from $2.64B, and net income of $1.18B, more than doubling from $570M. The Industrial segment surged 56% YoY and Communications grew 79%, while Automotive revenue was nearly flat at +2% YoY. The company also recorded $29.1M in new employee severance costs under global repositioning actions during the quarter.

• · Distributor channel revenue was $2.07B (57% of total) in Q2 FY2026, up from $1.48B (56%) in Q2 FY2025.
• · Direct customer revenue was $1.52B (42% of total) in Q2 FY2026, up from $1.13B (43%) in Q2 FY2025.
• · Accrued special charges for global repositioning actions stood at $13.4M at May 2, 2026, down from $31.2M at January 31, 2026, after $17.9M in severance payments during Q2.
• · Total assets measured at fair value were $2.23B as of May 2, 2026, including $703M in government/institutional money market funds and $398M in corporate obligations (Level 2).
• · Total liabilities measured at fair value were $33.9M, consisting of forward foreign currency exchange contracts ($10.0M) and interest rate derivatives ($23.9M).
• · Other comprehensive income for Q2 FY2026 was $2.3M, driven by foreign currency translation gains ($1.3M) and derivative gains ($0.6M).
• · Provision for income taxes increased to $148.5M in Q2 FY2026 from $56.2M in Q2 FY2025, reflecting higher pre-tax income.

20-05-2026

PrimeEnergy Resources reported a 52.5% decline in net income for Q1 2026 to $4.3M vs $9.1M in Q1 2025, driven by a steep loss in natural gas revenues and a $1.94M unrealized derivative loss. Total revenues fell 21.3% to $39.4M, though oil sales grew 8.3% to $35.4M. The company improved cash and cash equivalents to $19.4M from $7.4M at year-end 2025, but operating cash flow dropped 57.9% to $16.1M.

• · Natural gas revenue turned negative at -$1.02M in Q1 2026, compared to +$6.03M in Q1 2025, likely due to unfavorable pricing or hedging settlements.
• · Natural gas liquids revenue fell 39.3% to $5.18M from $8.53M.
• · A $1.94M unrealized loss on derivative instruments was recorded in Q1 2026, with no such loss in Q1 2025.
• · Field service revenue declined 16.7% to $1.79M and field service expenses dropped 36.5% to $1.18M.
• · Gain on disposition of assets was only $16K vs $619K in the prior year.
• · Property expenditures plummeted 95.7% to $1.5M from $34.7M, indicating significantly reduced capital spending.
• · The company had no long-term bank debt in Q1 2026 vs $24M borrowed and $21.5M repaid in Q1 2025.
• · Deferred income taxes swung to a benefit of $3.1M in Q1 2026 from a provision of $2.0M in Q1 2025.
• · Accrued liabilities increased slightly to $26.7M from $26.2M, but compensation-related accruals dropped significantly from $10.7M to $4.8M.
• · Accounts payable fell to $7.6M from $11.0M, driven by a $3.4M decline in trade payables.
• · Total equity rose slightly to $217.4M from $215.7M, mostly from net income partially offset by treasury stock purchases.

20-05-2026

Cyber Enviro-Tech, Inc. (CETI) filed its 10-K for the year ended December 31, 2025, reporting no revenue for the second consecutive year and a net loss of $7,640,973, which widened 20.0% from a net loss of $6,365,984 in 2024. The company's operating loss increased 9.4% to $3,116,470, while total liabilities rose to $5,090,572 from $4,067,950, and stockholders' deficit deepened to ($3,101,224) from ($502,259). However, cash used in operating activities improved to $2,885,340 from $3,496,740, and the company raised $3,889,289 in financing activities, primarily from convertible notes.

• · Total assets decreased 44.2% from $3,565,691 in 2024 to $1,989,348 in 2025, primarily due to the reclassification of $2,081,952 in assets of discontinued operations to zero.
• · Convertible notes payable (current and non-current) increased from $1,943,484 in 2024 to $2,560,009 in 2025, a 31.7% increase.
• · Derivative liability surged 176.8% from $387,238 in 2024 to $1,071,944 in 2025.
• · Accumulated deficit deepened 58.1% from ($13,129,093) to ($20,753,574).
• · The company had a loss on sale of the Alvey oil field of $1,241,110 in 2025.
• · Non-cash shares issued for conversion of convertible notes and accrued interest totaled $4,139,034 in 2025, up from $1,695,000 in 2024.
• · Debt discount on convertible notes payable was ($1,504,245) in 2025, compared to $337,889 in 2024.
• · The company had $215,000 in loans receivable and $203,368 in investment in WTXR as of December 31, 2025.
• · Contingent liabilities decreased from $437,500 to $190,000.
• · The company had a net change in cash from continuing operations of $17,599 in 2025, compared to ($1,261,668) in 2024.
• · Cash paid for interest was $19,156 in 2025, compared to $0 in 2024.
• · The company had 13,663,352 shares of common stock to be issued as of December 31, 2025, up from 2,973,132 in 2024.
• · Potentially dilutive shares totaled 132,414,568 as of December 31, 2025, up from 97,320,540 in 2024.
• · The company had no revenue and no cost of sales in both 2025 and 2024.

20-05-2026

CAVA Group reported revenue of $438.3M for the 16 weeks ended April 19, 2026, up 32.1% from $331.8M in the prior-year period, driven by restaurant revenue growth. However, net income declined to $23.6M from $25.7M, and diluted EPS fell to $0.20 from $0.22, as operating expenses grew faster than revenue. The company also reported an unrealized loss on investments and a decrease in comprehensive income.

• · Restaurant operating expenses increased 32.2% YoY to $327.1M, outpacing revenue growth.
• · General and administrative expenses rose 24.6% YoY to $51.6M.
• · Depreciation and amortization increased 22.4% YoY to $25.5M.
• · Pre-opening costs grew 37.5% YoY to $6.2M.
• · Impairment and asset disposal costs surged 63.1% YoY to $2.7M.
• · Interest income, net decreased 11.6% YoY to $4.1M.
• · The company invested $5.0M in a convertible promissory note during the period.
• · Cash paid for income taxes was $0.3M, down from $1.3M in the prior year.
• · CAVA Rewards and gift card liabilities decreased to $5.9M from $6.8M at the start of the period.
• · Total assets increased 4.6% to $1.42B from $1.36B at year-end 2025.
• · Accumulated deficit improved to $(230.0M) from $(253.6M) at year-end 2025.
• · The company had an unrealized loss on investments of $0.1M (net of tax) in the current period.

20-05-2026

Webstar Technology Group Inc. (WBSR) reported a net loss of $1,448,672 for the three months ended March 31, 2026, a significant increase from a net loss of $61,378 in the same period of 2025. The company has no revenue and its operating loss widened to $152,746 from $41,378, driven by higher general and administrative expenses. However, the company's cash position declined to $1,271 from $4,271 at year-end 2025, and total liabilities exceeded total assets, resulting in a stockholders' deficit of $3,693,173.

• · Interest expense – original issuance discount was $638,424 in Q1 2026 vs. $0 in Q1 2025.
• · Total other expense increased to $1,295,926 in Q1 2026 from $20,000 in Q1 2025.
• · Net cash used in operating activities was $512,908 in Q1 2026 vs. $31,341 in Q1 2025.
• · The $33.7 million Purchase Money Promissory Note (Forge/Atlanta subsidiary) matured on April 1, 2026 and is in default; interest accrues at 12.5% per annum.
• · The company is in discussions to restructure the $33.7 million note, with a proposed extension to October 1, 2026 and additional fees.
• · As of the filing date, $325,000 of the $500,000 purchase price for the Series A Preferred Stock remained unpaid to the seller.
• · James Owens remains the controlling stockholder because the Preferred Stock is held in escrow with voting rights retained by the seller.
• · The company had no revenue in either Q1 2026 or Q1 2025.

20-05-2026

Digital Brands Group, Inc. (DBGI) reported a net loss of $11.4M for Q1 2026, widening sharply from a $2.1M loss in Q1 2025, as net revenues fell 29.7% to $1.3M from $1.9M. Gross profit collapsed to $45,381 from $872,455, while operating expenses surged 160% to $7.5M, driven by a 473% increase in sales and marketing costs. The company's cash position improved to $5.1M from $1.9M at year-end 2025, but total liabilities rose to $43.7M and stockholders' equity dropped to $3.6M from $8.8M.

• · Net loss per common share (basic and diluted) was $(1.06) for Q1 2026, compared to $(0.92) for Q1 2025.
• · Cash used in operating activities was $4.7M in Q1 2026, slightly higher than $4.5M in Q1 2025.
• · The company had $5.1M in cash and cash equivalents at March 31, 2026, up from $1.9M at December 31, 2025, but restricted cash dropped to zero from $5.7M.
• · Inventory increased to $3.5M from $3.1M, with finished goods rising to $2.7M from $1.6M.
• · Goodwill remained unchanged at $5.8M, allocated to Bailey ($2.1M) and Sundry ($3.7M).
• · Total current liabilities increased to $26.8M from $26.1M, while total liabilities rose to $43.7M from $35.7M.
• · Share based payment liability increased to $12.5M from $9.4M, contributing to a $3.9M non-cash charge.
• · Proceeds from exercise of warrants provided $2.6M in financing during Q1 2026.

20-05-2026

I-ON Digital Corp. reported net income of $4.1M for Q1 2026, a significant turnaround from a net loss of $348k in Q1 2025, driven by a $4.1M gain on exchange of intangible assets and $441k gain on debt settlement. Revenue was $27k compared to zero in the prior year. However, operating loss widened to $391k from $348k, and cash used in operations increased to $391k from $287k. Total assets grew to $22.9M from $18.3M, while accumulated deficit improved to $4.1M from $8.3M.

• · Total current assets increased to $432k from $292k, driven by higher cash and other receivables.
• · Intangible assets, net increased to $22.5M from $18.0M, primarily due to exchange of intangible assets.
• · Convertible notes payable, net of discount, of $183k were issued during Q1 2026.
• · Derivative liability increased to $790k from $157k.
• · Loans payable of $550k were fully settled during Q1 2026.
• · Non-cash financing activities included settlement of bridge loans and accrued interest using ION.au units valued at $1.33M.
• · Weighted-average common shares outstanding – basic was 34,106,234 for Q1 2026 vs 31,106,234 for Q1 2025.
• · Diluted EPS was $0.04 for Q1 2026 vs $(0.01) for Q1 2025.

20-05-2026

USA OPPORTUNITY INCOME ONE, INC. reported a net loss of $66,823 for Q1 2026, widening from a $45,592 loss in Q1 2025, driven by higher operating expenses. Total assets increased to $34,359 from $4,995 at year-end 2025, while total liabilities rose to $927,244 from $831,057. The company has no revenue and continues to rely on debt and related-party advances.

• · General & administrative expense increased to $60,031 in Q1 2026 from $39,790 in Q1 2025.
• · Interest expense on bonds rose to $6,792 in Q1 2026 from $5,867 in Q1 2025.
• · Unrestricted cash increased to $34,359 as of March 31, 2026 from $4,995 as of December 31, 2025.
• · Accounts payable increased to $37,245 as of March 31, 2026 from $16,058 as of December 31, 2025.
• · Bonds issued and outstanding at par total $260,000 as of March 31, 2026 (current $170,000 + non-current $90,000).
• · The company has no revenue and no provision for income taxes.
• · Net loss per share was $(22.27) for Q1 2026 versus $(15.20) for Q1 2025.
• · Stockholders' deficit worsened to $(892,885) from $(826,062) at year-end 2025.
• · Principal repayment schedule shows $150,000 due in 2026, $45,000 in 2027, $65,000 in 2029.

20-05-2026

POWERDYNE INTERNATIONAL, INC. reported a net loss of $120,246 for Q1 2026, more than doubling the $55,134 loss in Q1 2025, as revenue declined 36.9% to $171,025 from $271,056. The company's cash position fell sharply to $24,271 from $47,382 at year-end 2025, while total assets decreased to $318,152 from $341,922. Stockholders' deficit widened to ($507,700) from ($504,954), and the company continues to rely on related-party loans and a line of credit for financing.

• · Trade accounts receivable plummeted to $4,334 at March 31, 2026 from $76,018 at December 31, 2025, a 94.3% decline.
• · Inventories decreased to $66,182 from $94,555, a 30.0% drop.
• · Accounts payable and accrued expenses fell to $56,950 from $109,742, a 48.1% reduction.
• · Due to related party - CEO increased to $273,591 from $250,591, a 9.2% rise.
• · Loans from related parties grew to $64,500 from $40,000, a 61.3% increase.
• · Operating cash flow used was $70,611 in Q1 2026, improving from $84,504 used in Q1 2025.
• · Financing activities provided $47,500 in Q1 2026, primarily from related-party loans.
• · The company issued 25,000,000 common shares for services valued at $117,500 during Q1 2026.
• · Basic and diluted loss per share remained $0.00 for both periods due to the high share count.
• · The company had a working capital deficit of $507,700 at March 31, 2026 (current liabilities of $771,302 vs current assets of $263,602).

20-05-2026

RELIABILITY INC (RLBY) reported Q1 2026 revenue of $5.55M, up 17.0% YoY from $4.75M, driven by strong growth in the EOR segment (+19.7% to $4.50M) and Staffing (+7.0% to $1.00M). However, the company posted a net loss of $119K, a significant improvement from a $333K loss in Q1 2025, while operating cash flow turned negative at -$505K versus positive $959K in the prior year. Gross margin improved slightly to 13.9% from 13.5%, but total equity declined to $6.55M from $6.67M at year-end 2025.

• · Factoring liability increased to $1.11M from $0.46M at year-end 2025.
• · Trade receivables net of allowance rose to $2.47M from $1.59M, with factored receivables increasing to $1.18M from $0.49M.
• · Selling, general and administrative expenses decreased 16.3% YoY to $856K from $1.02M.
• · Interest income from related parties fell to $65K from $126K YoY.
• · Interest expense declined to $20K from $52K YoY.
• · Cash paid for interest was $20K in Q1 2026 vs $52K in Q1 2025; income taxes paid were $14K vs $0.
• · The company had 300,000,000 shares outstanding; a subsequent return of shares occurred effective April 2, 2026 (per Note 10).
• · Video Production segment revenue grew 20.4% YoY to $59K, while Direct Hire had zero revenue in Q1 2026 vs $10K in Q1 2025.

20-05-2026

Plum Acquisition Corp. III reported a net income of $4.4M for Q1 2026, a significant turnaround from a net loss of $364,540 in Q1 2025, driven primarily by a $4.6M gain on the change in fair value of warrant liabilities. However, operating losses improved but remained negative at $237,912 (vs. $532,731 in Q1 2025), and cash dropped sharply from $49,870 to just $438, while total assets declined from $579,291 to $531,391.

• · The company is a shell company and an emerging growth company.
• · Class A ordinary shares subject to possible redemption were 42,486 shares at a redemption value of approximately $11.72 per share as of March 31, 2026 (vs. $11.64 at December 31, 2025).
• · Net cash used in operating activities improved to $89,432 in Q1 2026 from $285,965 in Q1 2025.
• · No cash was provided by investing activities in Q1 2026, compared to $23,977,494 in Q1 2025 (which included $23,975,464 transferred from Trust Account to pay redeeming shareholders).
• · Proceeds from promissory note - related party were $40,000 in Q1 2026 vs. $350,000 in Q1 2025.
• · Total current liabilities increased slightly to $6,212,409 as of March 31, 2026 from $6,025,804 as of December 31, 2025.
• · Accumulated deficit improved to $8,134,378 as of March 31, 2026 from $12,527,667 as of December 31, 2025.
• · Basic and diluted net income per share for both redeemable and non-redeemable shares was $0.55 in Q1 2026, compared to a loss of $0.04 per share in Q1 2025.

20-05-2026

Renewal Fuels, Inc. (RNWF) reported a net loss of $669,750 for Q1 2026, a significant increase from the $100,000 loss in Q1 2025, driven by a surge in operating expenses to $632,583 from $100,000. Cash and cash equivalents rose sharply to $99,594 from $2,525 at year-end 2025, primarily due to $513,000 in proceeds from prepaid warrants. However, the company remains deeply insolvent with a stockholders' deficit of $1,110,070 and total liabilities of $1,209,664 exceeding total assets of $99,594.

• · Operating expenses surged to $632,583 in Q1 2026 from $100,000 in Q1 2025, driven by $390,104 in professional fees and $190,932 in advertisement and marketing expenses.
• · Cash provided by financing activities was $513,000 from prepaid warrants, while cash used in operating activities was $415,931.
• · Notes payable to related parties increased to $491,186 from $473,523, with the largest being the CMB Communications June 2023 Note at $157,026.
• · Litigation liability rose slightly to $682,381 from $671,377.
• · The company has a net operating loss carryforward of $20,825,433, fully offset by a valuation allowance, resulting in no deferred tax asset.
• · Common stock issuable of $240,000 was recorded at March 31, 2026, compared to $0 at December 31, 2025.
• · Additional paid-in capital decreased sharply to $5,284,199 from $16,216,112, reflecting stock-based compensation and warrant issuances.

20-05-2026

TruGolf Holdings reported a net loss of $1.45M for Q1 2026, a significant improvement from the $2.67M loss in Q1 2025, driven by a 15% reduction in operating expenses. However, total revenue declined 4.2% YoY to $5.02M, primarily due to a 5.9% drop in golf simulator sales, while content software subscriptions grew modestly. The company's cash position decreased to $10.9M from $12.6M at the end of Q1 2025, and total liabilities increased to $17.1M from $15.9M at year-end 2025.

• · Net loss per share improved from $(44.24) in Q1 2025 to $(2.75) in Q1 2026, largely due to a significant increase in weighted average shares outstanding from 60,356 to 527,000.
• · Interest expense dropped 86.1% YoY from $1.49M to $207,163, contributing to the narrower net loss.
• · Cash used in operating activities improved to $(122,196) from $(449,119) in the prior year period.
• · Capitalized software development costs increased to $4.23M from $3.63M at year-end 2025, reflecting continued investment.
• · The company repurchased $345,000 of treasury stock during Q1 2026.
• · Deferred revenue rose to $6.61M from $5.56M at December 31, 2025, indicating growth in advance payments from customers.
• · Accounts payable increased to $3.19M from $2.77M at year-end 2025.
• · No franchise revenue was recorded in Q1 2026 compared to $13,125 in Q1 2025.

20-05-2026

Collab Z Inc. reported strong revenue growth for the three and six months ended March 31, 2026, with total revenue increasing 106% to $778,949 and 56% to $1,262,192, respectively, driven by consulting services and related-party revenue. Net income surged to $192,224 (Q3) and $286,936 (six months), compared to $27,853 and $141,188 in the prior year periods. However, cash from operations turned negative at -$271,017 for the six months, versus positive $128,796 a year ago, and cash and restricted cash at period end was $2,773,369, largely due to $2,762,575 in restricted cash from a Series C preferred stock issuance.

• · Revenue from related parties was $392,777 (Q3) and $776,373 (six months), up from $295,769 and $525,636 respectively.
• · Consulting services revenue (non-related) was $365,000 (Q3) and $445,000 (six months), compared to $70,000 and $270,000.
• · Property management revenue (non-related) was $21,172 (Q3) and $40,819 (six months), up from $12,549 and $12,549.
• · Sales and marketing expenses surged to $141,881 (Q3) and $201,801 (six months) from $5,722 and $10,248.
• · General and administrative expenses were $335,977 (Q3) and $597,814 (six months), up from $244,764 and $466,555.
• · Interest expense was zero for both periods in FY26, compared to $14,296 (Q3) and $23,006 (six months) in FY25.
• · Loss on joint ventures was $2,754 (Q3) and $516 (six months) in FY26, with no such loss in prior year.
• · Total assets increased to $5,669,618 from $2,490,483, primarily due to restricted cash and Series C preferred stock issuance.
• · Total liabilities increased to $614,025 from $453,566.
• · Mezzanine equity includes $2,792,615 of Series C redeemable convertible preferred stock (688,250 shares) issued during the six months.
• · Retained earnings grew to $973,168 from $767,107, after preferred stock dividends of $80,875 for the six months.
• · Deferred revenue remained unchanged at $35,000.
• · Capitalized software development costs were $129,993 (six months) vs $19,500 in prior year.
• · Loan receivable decreased to $314,668 from $552,059, with $250,000 in repayments.
• · Accounts receivable increased significantly to $489,684 from $86,972, and related-party receivables to $586,227 from $266,580.

20-05-2026

KonaTel, Inc. reported a net loss of $282,590 for Q1 2026, a significant improvement from the $917,528 net loss in Q1 2025. Revenue declined 12.2% to $1,905,062 from $2,168,714 in the prior year period, but gross profit improved 23.6% to $805,604 due to a sharp reduction in cost of revenue. The company's cash position decreased to $665,068 from $704,867 at year-end 2025, and total stockholders' equity fell to $196,220 from $384,205.

• · Operating loss improved to $281,215 from $929,645 in Q1 2025, a 69.7% improvement.
• · Cost of Revenue decreased 27.5% to $1,099,458 from $1,516,821, driving the gross profit improvement despite lower revenue.
• · Payroll and Related Expenses decreased 30.9% to $601,643 from $871,362.
• · Stock Option Expense decreased 60.5% to $94,605 from $239,337.
• · Professional and Other Expenses decreased 46.7% to $83,942 from $157,431.
• · Cash used in operating activities was $39,650 in Q1 2026, compared to cash provided by operations of $269,037 in Q1 2025.
• · Accounts Receivable decreased 49.7% to $142,884 from $284,167, providing $121,781 in operating cash flow.
• · Total liabilities increased slightly to $2,090,251 from $2,080,074.
• · The company's accumulated deficit grew to $10,366,733 from $10,084,143.
• · No income tax expense was recorded for either period.

20-05-2026

Nutra Pharma Corp (NPHC) filed its 10-K for the year ended December 31, 2025, reporting net sales growth of ~4.6% YoY to $385,307 (including related-party sales). However, the company's operating loss widened to ($1,462,338) from ($878,421) in 2024, driven by a sharp increase in operating expenses, particularly professional fees and consulting costs. The net loss grew to ($2,047,392) from ($1,285,663), and the company's total stockholders' deficit worsened to ($16,825,306). Key balance sheet concerns include very high current liabilities ($17.27M vs $0.46M current assets) and an accumulated deficit of ($78.28M). The independent auditor is Astra Audit & Advisory, LLC (PCAOB ID:6920).

• · The company's auditor is Astra Audit & Advisory, LLC (PCAOB ID: 6920), based in Tampa, FL.
• · Common shares authorized are 12,000,000,000; issued and outstanding are 7,099,727,214 as of Dec 31, 2025.
• · 220 million common shares to be issued for stock-based compensation in 2025 (value $30,000).
• · There was a $52,800 change in allowance for credit losses in 2025 (none in 2024), related to a receivable from sale of Stemsation stocks (zero balance in 2025 vs $52,800 in 2024).
• · A reserve for supplier advances of $5,000 in 2025 vs $60,000 in 2024 was recorded.
• · Net gain on settlement of debt/accrued expense/vendor payable was $53,526 in 2025 vs $33,778 in 2024.
• · The company has zero operating lease right-of-use assets as of Dec 31, 2025 (was $90,783 in 2024), and zero security deposit (was $8,803).
• · Inventory (less current portion) declined to $99,170 from $114,670.
• · SBA notes payable total $149,169 ($12,525 current + $136,644 non-current) as of Dec 31, 2025.
• · The company is unable to generate profits, has a material accumulated deficit, and faces a going concern risk.
• · Related party transactions include raw material purchases of $37,416 in 2025 (none in 2024) and interest expense to a related party of $22,870 (vs $21,237 in 2024).

20-05-2026

Flex Ltd. reported net sales of $27,914M for fiscal year 2026, an 8.1% increase from $25,813M in fiscal 2025, driven by strong growth in Cloud and Power Infrastructure (+37.8%). However, the Integrated Technology Solutions segment declined 2.0% and Regulated Manufacturing Solutions grew only 5.3%. Net income attributable to Flex Ltd. rose to $880M from $838M, a 5.0% increase, while diluted EPS improved to $2.33 from $2.11. Free cash flow decreased slightly to $1,060M from $1,082M, and the effective tax rate increased to 23.0% from 18.1%.

• · Net sales by region: Americas $13,820M (50% of total), Asia $8,401M (30%), Europe $5,693M (20%).
• · Net sales by country: Mexico $6,994M (25%), U.S. $5,186M (19%), China $4,494M (16%), Malaysia $2,967M (11%), Brazil $1,558M (6%), Hungary $1,327M (5%), Other $5,388M (18%).
• · Total contractual obligations as of March 31, 2026: $5,755M, with $672M due within 1 year.
• · Bank borrowings and long-term debt total $3,768M, with no current portion due within 1 year.
• · Accounts receivable increased to $4,679M from $3,671M, and inventories rose to $5,845M from $5,071M.
• · Accounts payable increased significantly to $8,055M from $5,147M.
• · Operating income grew to $1,368M from $1,169M, a 17.0% increase.
• · Restructuring charges totaled $59M in FY2026 vs $70M in FY2025.
• · Weighted-average basic shares outstanding decreased to 371M from 391M, reflecting share repurchases.
• · Net income from continuing operations was $880M in FY2026 vs $838M in FY2025, while in FY2024 it was $872M (excluding discontinued operations).

20-05-2026

Solidion Technology Inc. reported its first quarter results for 2026, generating $85,426 in net sales compared to zero revenue in the prior year period, marking its first revenue generation. However, the company posted a net loss of $1,430,668 versus net income of $9,194,630 in Q1 2025, and cash declined sharply to $38,887 from $204,725 at year-end 2025, reflecting ongoing cash burn and a deteriorating liquidity position.

• · Gross profit was $83,730 in Q1 2026, compared to $0 in Q1 2025.
• · Cost of goods sold was $1,696 in Q1 2026, compared to $0 in Q1 2025.
• · Operating loss improved to $1,774,293 in Q1 2026 from $3,132,669 in Q1 2025.
• · Stock-based compensation was $277,654 in Q1 2026, down from $754,361 in Q1 2025.
• · Depreciation and amortization was $67,400 in Q1 2026, compared to $69,942 in Q1 2025.
• · Net cash used in operating activities was $141,863 in Q1 2026, significantly improved from $2,342,278 in Q1 2025.
• · Net cash used in investing activities was $23,975 in Q1 2026, compared to $40,156 in Q1 2025.
• · No financing cash flows in Q1 2026; Q1 2025 had $198,875 provided by financing activities.
• · Accounts payable and accrued expenses increased by $2,043,286 during Q1 2026.
• · Excise tax payable was $1,060,321 at March 31, 2026, up from $964,463 at December 31, 2025.
• · Due to related party was $162,873 at March 31, 2026, up from $87,873 at December 31, 2025.
• · Deferred offering costs of $460,915 were recorded at March 31, 2026, with none at year-end 2025.
• · Other current assets increased to $447,329 from $76,166.
• · Prepaid expenses decreased to $66,818 from $170,257.
• · Accounts receivable increased to $15,624 from $5,110.
• · Inventory remained unchanged at $24,430.
• · Other receivable remained unchanged at $302,500.
• · Land improvements, buildings, building improvements, and machinery and equipment balances were unchanged from December 31, 2025.
• · Accumulated depreciation increased to $3,868,469 from $3,820,893.
• · Issued patents gross carrying amount increased to $1,605,525 from $1,585,894.
• · Patents pending increased to $1,159,540 from $1,155,196.
• · Prior-period errors corrected in 2025 restatement: warrant remeasurement ($5,735,883), issuance of FPA shares ($3,124,379), FPA subscription receivable discount ($93,113).
• · Stock subscription receivable increased to $2,919,674 from $2,841,427.
• · Additional paid-in capital increased to $159,453,519 from $159,027,646.
• · Common stock par value increased to $774 from $746 due to issuance of 280,400 shares (240,400 upon warrant settlement and 40,000 to consultants).

20-05-2026

RetinalGenix Technologies Inc. (RTGN) reported a net loss of $590,489 for the three months ended March 31, 2026, slightly wider than the $587,259 loss in the same period of 2025. The company remains pre-revenue with zero revenues in both periods. Operating expenses increased marginally to $589,229 from $586,350, driven by a significant jump in R&D spending ($117,064 vs. $13,214), partially offset by lower G&A and stock-based compensation. Cash at end of period was only $180, down from $3,711 a year earlier, highlighting severe liquidity constraints.

• · Net loss per share remained flat at $(0.03) for both Q1 2026 and Q1 2025.
• · Stockholders' deficit worsened to $(2,558,084) at March 31, 2026 from $(2,302,611) at December 31, 2025.
• · Accumulated deficit increased to $(18,449,106) at March 31, 2026 from $(17,858,617) at December 31, 2025.
• · Cash used in operating activities improved to $(109,213) in Q1 2026 from $(187,222) in Q1 2025.
• · No stock options or warrants were granted, exercised, or canceled during Q1 2026.
• · All 780,000 outstanding stock options are exercisable at March 31, 2026.
• · The company has two product candidates: RTG-2023 for dry AMD and RTG-2024 for Alzheimer’s syndrome dementia.

20-05-2026

VisitIQ Corp. filed its 10-K for the fiscal year ended August 31, 2025, reporting a net loss of $8,152,593, an improvement of 23.9% from the prior year's loss of $10,706,334. Total revenue declined 12.1% to $2,635,730, driven by a 54.9% drop in media activation revenue, though data revenue grew 7.5% to $2,212,601. The company achieved a gross profit of $1,428,369 compared to a gross loss of $1,184 in 2024, but operating expenses increased 7.8% to $8,746,262, and the company remains in a stockholders' deficit of $13,982,755.

• · Bookings surged 637.3% to $4,379,609 in FY2025 from $593,999 in FY2024.
• · Cash balance fell 72.1% to $107,561 as of August 31, 2025, from $386,002 a year earlier.
• · Total current liabilities decreased 82.3% to $4,162,310, primarily due to a reduction in convertible notes payable from $19,456,679 to $2,082,801.
• · Stockholders' deficit improved 41.2% to $13,982,755 from $23,797,804, driven by additional paid-in capital of $17,909,202 from the issuance of Series C convertible preferred stock.
• · Net cash used in operating activities improved 44.1% to $2,619,662 from $4,684,082.
• · The company recognized a $442,638 gain on exchange of convertible notes for preferred stock and a $481,717 loss upon dissolution of DrivenIQ.
• · Stock-based compensation expense of $2,947,578 was recorded in FY2025, compared to none in FY2024.
• · Allowance for credit losses increased to approximately $121,000 from $47,000.
• · The company's long sales cycles are noted as a risk factor, making revenue projection difficult.

20-05-2026

Sachem Capital Corp. reported a net loss of $6.1M for Q1 2026, a sharp reversal from net income of $0.9M in Q1 2025, driven by a $5.4M provision for credit losses (vs. $1.1M a year ago) and $1.6M in transaction expenses. Net interest income declined 4.9% to $3.6M, while total assets grew 2.9% to $473.3M. The net loss attributable to common shareholders was $7.2M, or $(0.15) per share, compared to a loss of $0.2M in the prior-year period.

• · Interest income from loans increased 11.0% YoY to $8.8M, but interest income from LLC investments fell 55.8% to $0.9M.
• · Total operating expenses rose 73.1% to $5.7M, driven by a $1.6M transaction expense and higher compensation costs.
• · Net cash provided by operating activities improved to $0.8M from $0.2M in Q1 2025.
• · Investing activities used $16.5M in cash, compared to providing $5.7M a year ago, primarily due to lower loan principal collections.
• · Financing activities provided $16.3M, largely from $10.0M in new senior secured notes and net line of credit borrowings.
• · Loans held for investment, net, decreased 6.2% to $341.2M from $363.7M at year-end 2025.
• · Investments in developmental real estate surged to $46.0M from $9.7M at December 31, 2025, reflecting a $35.9M restructuring of a loan held for investment.
• · The allowance for credit losses on loans increased to $12.4M from $11.5M at year-end 2025.
• · Dividends paid on common shares totaled $2.4M, up slightly from $2.4M in Q1 2025.

20-05-2026

Starfighters Space, Inc. reported a net loss of $4.27M for Q1 2026, widening from a $2.65M loss in Q1 2025, driven by a 116% surge in operating expenses to $4.05M. Cash and restricted cash fell to $2.14M from $4.63M at year-end 2025, while total assets declined to $26.34M from $28.39M. However, the company raised no new equity in the quarter and recorded a $1.53M due from shareholder and a $395k loss from misappropriation of assets.

• · Stock-based compensation of $1.80M was the largest non-cash expense in Q1 2026, up from $0 in Q1 2025.
• · Professional fees surged to $1.33M in Q1 2026 from $192k in Q1 2025.
• · Consulting fees increased to $1.12M from $390k year-over-year.
• · Advertising and promotion expenses rose to $508k from $81k.
• · The company recorded a $395k loss from misappropriation of assets in Q1 2026.
• · A $1.53M due from shareholder was recorded as of March 31, 2026, with a corresponding related party notes payable of the same amount.
• · Short-term investments decreased to $13.21M from $15.27M at year-end 2025.
• · Restricted cash increased to $736k from $51k at December 31, 2025.
• · Grant payable increased to $744k from $355k at year-end 2025.
• · Net cash used in operating activities was $3.96M in Q1 2026 vs $1.67M in Q1 2025.
• · No proceeds from private placements or financing activities in Q1 2026, compared to $4.10M in Q1 2025.
• · All convertible notes (Tranches 1-5) were fully converted by December 31, 2025, with no remaining balance.
• · Net loss per share improved to $(0.10) from $(0.13) due to a higher share count.

20-05-2026

American Resources Corp (AREC) reported a net income attributable to shareholders of $55.4M in fiscal 2025, a significant turnaround from a net loss of $39.1M in 2024, driven primarily by $73.2M in income from discontinued operations. However, the company generated zero revenue from continuing operations in 2025, compared to $34,070 in 2024, and continued to record losses from operations of $11.3M (improved from $14.2M in 2024). The company also experienced a substantial increase in cash and equivalents from $0.2M to $31.7M, largely due to $81.3M in financing activities, while investing activities consumed $39.4M.

• · Total assets decreased 40% to $168.9M from $281.7M, primarily due to discontinuation of operations.
• · Total liabilities decreased 79.1% to $75.7M from $362.6M, driven by the removal of $325.1M in discontinued operations liabilities.
• · Equity swung positive to $93.2M from a deficit of $80.9M.
• · Cash used in operating activities was $10.4M, worsening from $2.0M generated in FY2024.
• · Interest income surged to $577,526 from $78,791, while interest expense rose to $1,764,115 from $1,521,726.
• · Loss on debt extinguishment of $5.2M in FY2025 was a new expense, nil in 2024.
• · Number of shares outstanding increased by 37% to 106.9M from 78.0M, driven by debt/equity issuances and an equity offering.
• · Accounts receivable from related parties fell to $59.4M from $81.6M, but an allowance of $6.2M was established (none in 2024).
• · Investment in other entities (related parties) jumped to $32.4M from $1.7M.
• · Accounts payable to related parties rose to $51.6M from $17.5M.

20-05-2026

X3 Acquisition Corp. Ltd. (XCBE) reported net income of $913,196 for the three months ended March 31, 2026, driven by $1,486,330 in interest earned on marketable securities held in the Trust Account. The company completed its IPO during the quarter, raising $221,625,000 in net proceeds from the sale of Units and $5,375,000 from Private Placement Warrants, resulting in total assets of $227,870,716. However, the company incurred a loss from operations of $221,434 and had an accumulated deficit of $4,462,618 as of March 31, 2026.

• · The company had no cash at December 31, 2025, but ended March 31, 2026 with $921,248 in cash.
• · Total current liabilities increased from $291,763 at December 31, 2025 to $221,441 at March 31, 2026.
• · Deferred underwriting fee payable of $5,625,000 was recorded as of March 31, 2026.
• · Shareholders' deficit worsened from $44,205 at December 31, 2025 to $4,462,055 at March 31, 2026.
• · Net cash used in operating activities was $136,680 for the three months ended March 31, 2026.
• · The company invested $225,000,000 of cash into the Trust Account during the quarter.

20-05-2026

Cavitation Technologies, Inc. (CVAT) reported a net loss of $219,000 for the three months ended March 31, 2026, compared to a net loss of $230,000 in the same period last year, while revenue collapsed 97.5% to $3,000 from $122,000. For the nine-month period, the company swung to a net loss of $953,000 from net income of $122,000 in the prior year, driven by a 97% revenue decline to $6,000 and the absence of a prior-year $880,000 gain on patent assignment. The company's cash position deteriorated sharply to $45,000 from $249,000 at June 30, 2025, and stockholders' equity turned negative to ($467,000) from $69,000.

• · Total liabilities increased 133.8% to $533,000 from $228,000, driven by new promissory notes payable – related party ($91,000), convertible notes payable ($28,000), and derivative liability ($18,000).
• · Stockholders' equity turned negative to ($467,000) from $69,000 at June 30, 2025.
• · The company raised $173,000 from sale of common stock units and $90,000 from a note payable during the nine months ended March 31, 2026.
• · General and administrative expenses for the nine months increased 12.0% to $949,000 from $847,000, despite a 17.3% decline in the quarter.
• · Research and development expenses were zero in the current quarter, down from $42,000 in the prior-year quarter.
• · The company recorded a $20,000 gain from change in fair value of derivative liability in the current quarter, with no such item in the prior year.
• · Cash used in operating activities improved 15.5% to $527,000 from $624,000 in the prior-year nine-month period.
• · No revenue was generated from cost of revenue in either period, indicating no direct production costs.

20-05-2026

Roivant Sciences Ltd. reported a net loss attributable to the company of $299.8M for the fiscal year ended March 31, 2026, compared to a net loss of $172.0M in the prior year, while revenue declined 71.6% to $8.3M from $29.1M. The company recorded a $770.2M gain on litigation settlement and a $515.1M loss from operations, though operating loss improved from $1.0B in FY2025. Cash used in operations was $750.3M, and the company holds a $233.2M minority equity investment in Datavant valued using significant unobservable inputs.

• · Revenue declined for the second consecutive year, from $32.7M in FY2024 to $29.1M in FY2025 to $8.3M in FY2026.
• · Gain on sale of Telavant net assets was $0 in FY2026 vs $110.4M in FY2025 and $5.3B in FY2024.
• · Income tax expense increased 176.8% to $133.3M in FY2026 from $48.2M in FY2025.
• · Net cash used in investing activities was $682.3M in FY2026, compared to $1.8B used in FY2025.
• · Net cash provided by financing activities was $134.2M in FY2026 vs $1.2B used in FY2025.
• · The company's investment in Datavant is classified as Level 3 and valued at $233.2M using significant unobservable inputs including discount rate, revenue growth rate, EBITDA, and terminal growth rate.
• · Immunovant/HanAll anti-FcRn franchise has potential milestones up to $420M; Pulmovant/Bayer mosliciguat up to $280M.
• · Genevant/Arbutus LNP Technology entitles Roivant to up to 20% of royalty-related receipts.

20-05-2026

Immunovant, Inc. filed its 10-K for the fiscal year ended March 31, 2026, reporting a net loss of $505.6M, widening from $413.8M in FY2025 and $259.3M in FY2024. Revenue remained absent as the company continues to invest heavily in R&D, which increased 26.5% YoY to $456.7M. However, the company strengthened its balance sheet with cash and cash equivalents rising 26.4% to $902.1M, supported by $544.2M in net proceeds from an underwritten offering.

• · Net cash used in operating activities was $407.3M in FY2026, up from $375.9M in FY2025.
• · Stock-based compensation expense rose to $55.7M in FY2026 from $49.5M in FY2025.
• · Accrued expenses increased significantly to $96.6M as of March 31, 2026, from $50.7M a year earlier.
• · Accounts payable decreased to $7.5M from $17.7M.
• · The company had no revenue and no acquired in-process R&D in FY2026 or FY2025.
• · Total assets grew to $957.0M from $776.2M, primarily due to higher cash balances.
• · Total liabilities increased to $104.4M from $68.8M.
• · The company issued 26.2 million shares in an underwritten offering during FY2026, raising $543.7M before costs.

20-05-2026

Capstone Holding Corp. reported a net loss of $1.915M for Q1 2026, compared to a net loss of $2.433M in Q1 2025 (improvement of 21.3%). Net sales surged 60.0% to $12.636M from $7.899M, driven by acquisitions. However, gross profit margin declined to 23.5% from 16.8%, and operating loss widened to $1.497M from $1.428M. Cash used in operations increased to $2.789M from $2.269M, and total debt rose to $25.870M from $23.364M.

• · The company completed an acquisition in Q1 2026 with aggregate purchase consideration of $4.202M, including $2.702M cash, a $1.250M seller note, and a $250K earn-out. Identifiable net assets acquired were $3.444M, resulting in $758K goodwill.
• · In Q1 2025, the company completed a separate acquisition with aggregate purchase consideration of $6.261M, including $3.606M cash, $2.556M in seller notes, and $99K earn-out. Identifiable net assets were $5.660M, resulting in $601K goodwill.
• · Total debt (line of credit + current portion of long-term debt + long-term debt) increased to $25.870M as of March 31, 2026 from $23.364M as of December 31, 2025.
• · Interest expense rose to $892K in Q1 2026 from $300K in Q1 2025, a 197% increase.
• · Selling, general and administrative expenses increased to $4.467M from $2.753M, a 62.3% increase.
• · The company issued 322,500 shares of common stock under an equity line of credit, raising $189K in additional paid-in capital.
• · The company issued 333,335 shares of common stock upon conversion of Senior Convertible Notes, adding $280K to equity.
• · Derivative liability decreased sharply from $702K to $197K, with an unrealized gain of $476K recognized.
• · Accumulated deficit widened to $219.952M from $218.037M.
• · The company had a foreign currency translation gain of $13K in Q1 2026, compared to $0 in Q1 2025.

20-05-2026

AG Acquisition Group III, Inc. reported no revenue for the three and nine months ended March 31, 2026, consistent with the prior year periods. Net loss widened significantly to $8,365 for the quarter (vs. $2,185 in Q3 2025) and to $17,570 for the nine-month period (vs. $8,670 in the prior year), driven by higher professional fees. The company's cash position improved to $761 as of March 31, 2026, from $396 at June 30, 2025, but stockholders' equity turned negative to ($974) from positive $396, reflecting accumulated losses.

• · General and administrative - professional fees increased to $8,365 for the quarter (from $2,185) and to $17,570 for the nine months (from $8,670).
• · Accounts payable rose from $0 at June 30, 2025 to $1,735 at March 31, 2026.
• · Accumulated deficit grew to ($75,674) at March 31, 2026 from ($58,104) at June 30, 2025.
• · Stockholders' equity turned negative to ($974) at March 31, 2026 from positive $396 at June 30, 2025.
• · Cash used in operating activities increased to $15,835 for the nine months ended March 31, 2026 from $8,670 in the prior year period.
• · Stockholder contributions of $16,200 were received in the nine months ended March 31, 2026, up from $9,000 in the prior year period.

20-05-2026

Roman DBDR Acquisition Corp. II reported a net loss of $235,067 for Q1 2026, a sharp reversal from net income of $2,214,005 in Q1 2025, driven by a 452% surge in general and administrative expenses to $1,885,399. Interest earned on trust investments declined 27.8% to $1,650,332, while cash dropped 70.8% to $53,490, partially offset by $280,000 in related-party promissory note proceeds.

• · Total assets increased slightly to $243,056,081 as of March 31, 2026 from $241,506,267 at December 31, 2025.
• · Shareholders' deficit deepened to ($2,663,492) from ($778,093) due to the net loss and remeasurement of Class A shares.
• · Accounts payable and accrued expenses surged to $2,400,616 from $895,735, a 168% increase.
• · Net cash used in operating activities was $409,532 in Q1 2026 vs $323,430 in Q1 2025.
• · No investing or financing cash flows from unit or warrant sales occurred in Q1 2026; the only financing was $280,000 from a related-party promissory note.
• · Class A ordinary shares redemption value per share increased to $10.56 from $10.49 at year-end 2025.

20-05-2026

Cambium Networks Corp reported a significant improvement in Q1 FY2026 results, with total revenue increasing 32.1% YoY to $44.6M and net loss narrowing sharply from -$12.0M to -$3.4M. Product revenue grew 38.2% YoY to $40.2M, while subscriptions and services revenue declined 6.5% to $4.3M. However, the company's cash position deteriorated, with cash dropping from $11.1M to $5.9M during the quarter, and total shareholders' deficit widened from -$35.9M to -$38.6M.

• · Net cash used in operating activities improved slightly from -$4.8M to -$4.4M YoY.
• · Cash used in investing activities decreased from -$1.7M to -$0.8M YoY.
• · Inventories, net decreased from $27.5M to $25.9M during the quarter.
• · Receivables increased from $40.3M to $49.6M during the quarter.
• · Current portion of long-term debt, net remained high at $66.4M.
• · Accrued interest on debt increased from $5.1M to $6.9M during the quarter.
• · Share-based compensation decreased from $2.1M to $1.3M YoY.
• · Foreign currency translation loss of $0.5M in Q1 FY2026 vs. a gain of $0.1M in Q1 FY2025.
• · Gross inventory (before reserves) decreased from $56.4M to $54.3M.
• · Excess and obsolescence reserve remained high at $28.5M (52.4% of gross inventory).

20-05-2026

XWELL, Inc. reported a net loss of $11.2M for Q1 2026, more than doubling from a $4.7M loss in Q1 2025, driven by a $5.6M non-cash charge from the change in fair value of derivative liabilities and a 5.5% decline in total revenue to $6.6M. However, gross profit improved sharply to $2.4M from $1.3M, and the company strengthened its balance sheet by raising $28.3M in a Series H preferred stock private placement, extinguishing $9.0M of preferred stock and convertible notes, and boosting cash to $16.8M from $2.6M at year-end 2025.

• · Services revenue declined 5.5% YoY to $6.1M from $6.4M; product revenue fell 4.8% to $574K from $603K.
• · Cost of sales decreased 24.9% YoY to $4.3M, driven by a 25.0% drop in labor costs ($3.0M vs $4.0M) and a 32.9% drop in occupancy costs ($761K vs $1.1M).
• · General and administrative expenses surged 76.2% to $7.6M from $4.3M, largely due to stock-based compensation of $886K (vs $83K) and other non-cash charges.
• · The company recorded a $5.6M non-cash charge for the change in fair value of derivative liabilities, compared to a $142K charge in Q1 2025.
• · A $9.0M cash payment was made to repurchase preferred stock, convertible notes and warrants, funded by the $28.3M private placement.
• · Total equity swung from a deficit of $12.8M at year-end 2025 to positive equity of $10.1M at March 31, 2026.
• · Basic and diluted loss per share widened to $1.51 from $1.00, reflecting a higher net loss and increased share count.
• · Accumulated deficit grew to $500.9M from $489.7M at year-end 2025.

20-05-2026

TREASURE GLOBAL INC (TGL) reported a net loss of $2.32M for Q3 FY2026 (three months ended March 31, 2026), compared to net income of $1.26M in the same quarter last year, driven by a sharp decline in gross profit to just $6,415 from $486,283. Revenue grew 125% YoY to $1.50M, but cost of revenues surged to $1.49M, nearly matching revenue. For the nine-month period, the net loss widened to $7.56M from a prior-year net income of $0.08M, while cash and cash equivalents increased significantly to $2.91M from $0.24M at June 30, 2025, primarily due to financing activities.

• · Total operating expenses for the three months ended March 31, 2026 were $4,192,751, up from $529,692 in the prior year period, driven largely by a $3,811,991 general and administrative expense.
• · The company recorded a long-lived assets impairment of $3,044,877 in the nine months ended March 31, 2026.
• · Allowance for credit losses was $3,434,741 for the nine months ended March 31, 2026, compared to $90,480 in the prior year period.
• · Net cash used in operating activities for the nine months ended March 31, 2026 was $5,191,149, improving from $5,817,360 in the prior year period.
• · The company issued 1,675,725 common shares as of March 31, 2026, up from 207,470 as of June 30, 2025, reflecting significant equity financing activities including share purchase agreements, direct offerings, and warrant exercises.
• · Derivative liabilities increased to $1,165,795 as of March 31, 2026 from $383,886 as of June 30, 2025.
• · The company had no intangible assets as of March 31, 2026, down from $3,044,877 as of June 30, 2025, due to impairment.
• · Basic and diluted loss per share was $(1.39) for the three months ended March 31, 2026, compared to income per share of $21.79 in the prior year period.
• · The company effected a 1-for-50 reverse stock split on April 7, 2025 and a 1-for-20 reverse stock split on December 5, 2025.

20-05-2026

Ionetix Corp reported zero revenue and a net loss of $15,569 for the three months ended March 31, 2026, with total operating expenses of $15,261. The company's cash position declined sharply from $25,490 at December 31, 2025 to $10,229 at March 31, 2026, and its accumulated deficit expanded from $129 to $15,698, pushing stockholders' equity from positive $421 to negative ($15,148). The very early-stage / pre-revenue condition combined with the large increase in net loss and near-total capital burn is highly concerning.

• · No revenue generated in Q1 2026 (pre-revenue stage).
• · Operating expenses of $15,261 consisted of $11,597 in professional services, $3,569 in filing fees, and $95 in bank fees.
• · Interest expense of $308 was incurred, with $0 cash paid for interest.
• · Promissory note payable of $25,000 to related parties remained unchanged from prior quarter, with accrued interest payable increasing from $69 to $377.
• · Net deferred tax assets of $0 after a full valuation allowance; NOL carry-forwards increased from $27 to $3,297.
• · Weighted average common shares outstanding of 5,500,000 (basic and diluted); loss per share rounded to $0.00.

20-05-2026

AppYea, Inc. reported a net loss of $1.568M for Q1 2026, a significant increase from a $0.166M loss in Q1 2025, driven by higher operating expenses and a $0.386M change in fair value of derivative liabilities. The company had zero revenue in Q1 2026 compared to $3K in Q1 2025, and its accumulated deficit grew to $27.023M. However, cash and cash equivalents more than doubled to $0.811M from $0.408M at year-end 2025, supported by $0.698M in financing proceeds from stock issuances.

• · Total assets decreased slightly to $21.541M as of March 31, 2026 from $21.733M at December 31, 2025.
• · Total liabilities increased to $9.726M from $8.798M, primarily due to a $0.734M increase in derivative liability.
• · Stockholders' equity decreased to $11.815M from $12.935M, driven by the net loss.
• · Operating loss widened to $1.184M from $0.123M in Q1 2025, mainly due to $0.533M in amortization of intangible assets and higher G&A expenses.
• · The company issued 34,090,910 shares to investors in Q1 2026, raising $0.372M.
• · Net cash used in operating activities was $0.297M in Q1 2026 vs $0.103M in Q1 2025.
• · The company has a going concern uncertainty (Note 1D).
• · On August 20, 2025, AppYea acquired proprietary blockchain-based lottery and gaming technology from Techlott Enterprises Ltd. in exchange for common stock.

20-05-2026

20/20 Biolabs, Inc. (AIDX) reported a net loss of $2.17M for Q1 2026, significantly wider than the $0.76M loss in Q1 2025, driven by a 36% decline in revenue to $353,375 and a surge in operating expenses. However, the company strengthened its balance sheet by raising $5.0M from Series E preferred stock issuance, boosting cash to $4.22M from $1.03M at year-end 2025, and converted all outstanding preferred stock series into common stock, eliminating preferred stock liabilities.

• · All series of preferred stock (Series A, A-1, A-2, B, C, D) were converted into common stock during Q1 2026, eliminating those preferred stock liabilities.
• · The company issued 5,000 shares of Series E convertible preferred stock with a liquidation preference of $5,494,500.
• · Deferred revenue increased to $487,722 from $456,687 at year-end 2025, with OneTest commercial clients contributing $386,667.
• · Net cash used in operating activities was $1.29M in Q1 2026, compared to $0.49M in Q1 2025.
• · Non-cash items included a $322,359 loss on issuance of convertible note and a $148,766 loss on change in fair value of warrant liability.
• · Weighted-average common shares outstanding increased to 7,657,229 from 4,823,125 year-over-year.
• · Basic and diluted net loss per common share was $(0.28) in Q1 2026 versus $(0.16) in Q1 2025.

20-05-2026

OMNIQ Corp. reported Q1 2026 revenue of $7.68M, down 3.7% YoY from $7.98M, and a net loss of $1.65M (improved from $2.09M loss in Q1 2025). Gross profit increased slightly to $2.26M from $2.18M, but operating loss widened to $1.27M from $0.43M due to a 48.5% surge in SG&A expenses. The company ended the quarter with $0.79M cash, total assets of $25.55M, and a stockholders' deficit of $14.15M, reflecting ongoing financial challenges.

• · Operating loss widened to $1.27M from $0.43M in Q1 2025, a 197% increase.
• · SG&A expenses rose 48.5% to $2.77M from $1.87M.
• · Total liabilities increased to $39.70M from $38.87M as of Dec 2025.
• · Accounts receivable decreased to $8.16M from $9.54M, a 14.5% decline.
• · Inventory decreased to $3.25M from $3.41M.
• · Net cash used in operating activities was $0.07M, improved from $1.02M provided in Q1 2025 (which included discontinued operations).
• · Cash used in financing activities was $0.68M, primarily for debt repayments.
• · The company had a working capital deficit of $14.64M as of March 31, 2026.
• · Management plans to reduce operating expenses and focus on profitable product lines and prime customers.
• · Short-term liabilities decreased from $86.3M to $27.7M during 2025 due to debt settlements.

20-05-2026

Starco Brands reported a net loss of $797,965 for Q1 2026, compared to net income of $1,878,856 in Q1 2025, driven by a 8.6% decline in revenue to $8,979,270 and a swing to operating loss of $576,218 from operating income of $2,534,937. Cash decreased to $997,836 from $1,818,406 at year-end 2025, and total stockholders' equity fell to $13,621,353 from $14,198,239.

• · Total assets remained nearly flat at $35.87M as of March 31, 2026 vs $35.86M at Dec 31, 2025.
• · Total liabilities increased to $22.25M from $21.66M, driven by higher accounts payable and accrued liabilities.
• · Accumulated deficit widened to $103.15M from $102.35M.
• · Non-controlling interest decreased slightly to $9.05M from $9.08M.
• · Stock-based compensation decreased to $252,834 in Q1 2026 from $471,236 in Q1 2025.
• · Amortization of intangible assets decreased to $354,314 from $704,508.
• · The prior year Q1 2025 included a $3.69M fair value share adjustment gain, which did not recur in Q1 2026.
• · Net cash used in operating activities was $707,412 in Q1 2026 vs $839,143 provided in Q1 2025.
• · No investing activities in Q1 2026 vs $128,350 used in Q1 2025.
• · Financing activities used $113,158 in Q1 2026 vs $293,307 used in Q1 2025.
• · Weighted average shares outstanding (basic) increased to 784.2M from 647.4M due to stock issuances in prior periods.

20-05-2026

EnerSys reported fiscal 2026 net sales of $3,751.4M, up 3.7% from $3,617.6M in fiscal 2025, driven by growth in Energy Systems (+7.8%) and Specialty (+12.1%). However, net earnings attributable to stockholders declined 19.3% to $293.6M from $363.7M, as operating earnings fell 8.2% due to higher restructuring charges and other expenses. Gross profit margin contracted to 29.2% from 30.2%.

• · Primary operating capital decreased to $876.6M as of March 31, 2026 from $932.2M a year earlier.
• · Primary operating capital as a percentage of annualized net sales improved to 22.2% from 23.9%.
• · Cost of goods sold increased 5.2% to $2,651.5M, outpacing net sales growth.
• · Other (income) expense, net increased significantly to $28.5M from $7.0M, impacting earnings.
• · Motive Power segment operating earnings declined 14.2% to $199.8M, while Energy Systems and Specialty grew strongly.
• · Restructuring charges surged to $51.0M from $14.4M, primarily in Energy Systems and Motive Power.

20-05-2026

Charlie's Holdings, Inc. reported a net loss of $1.05M for Q1 2026, improved from a $1.217M loss in Q1 2025, driven by a 204% surge in product revenue to $4.804M. However, operating loss widened to $0.975M from $0.879M due to a 70% increase in operating expenses, and cash decreased 52% to $0.64M from $1.32M at year-end 2025.

• · Cash used in operating activities from continuing operations was $1.105M in Q1 2026, compared to $0.691M in Q1 2025.
• · Net cash provided by financing activities was $0.425M in Q1 2026, primarily from $0.51M in proceeds from issuance of common shares.
• · Accounts receivable increased to $1.273M from $0.44M at year-end 2025.
• · Deferred revenue rose to $0.26M from $0.038M at December 31, 2025.
• · The company issued 2.55 million common shares for cash ($0.51M) and 1 million common shares in lieu of redemption of notes payable to related parties ($0.2M) during Q1 2026.
• · Interest expense decreased sharply to $0.075M from $0.241M in Q1 2025.
• · No debt extinguishment loss was recorded in Q1 2026, compared to a $0.149M loss in Q1 2025.
• · Inventory reserves increased to $0.618M from $0.514M at year-end 2025.
• · Raw materials inventory surged to $3.891M from $0.494M at December 31, 2025.
• · Accumulated deficit grew to $9.25M from $8.2M at year-end 2025.

20-05-2026

Bayview Acquisition Corp reported a net loss of $367,344 for Q1 2026, compared to net income of $143,915 in Q1 2025, driven by higher formation and operating costs ($471,513 vs $270,459). Total assets increased to $12.14M from $11.81M, while accumulated deficit widened to $6.14M. The company continues to seek a business combination.

• · Basic and diluted net income per share for redeemable shares was $0.03 in Q1 2026 vs $0.09 in Q1 2025.
• · Basic and diluted net loss per share for non-redeemable shares was $(0.23) in Q1 2026 vs $(0.12) in Q1 2025.
• · Total liabilities increased to $6.26M as of March 31, 2026 from $5.57M as of December 31, 2025.
• · Cash provided by operating activities was $6,058 in Q1 2026 vs cash used of $41,019 in Q1 2025.
• · The company had $12.01M in investments held in trust account as of March 31, 2026.
• · Promissory notes – extension increased to $1.925M from $1.775M.

20-05-2026

AEVEX Corp. reported a net income of $20.998M for Q1 2026, a significant turnaround from a net loss of $27.322M in Q1 2025. Revenue surged to $216.693M from $53.258M, driven by a product revenue increase from $26.487M to $191.844M. However, cash flow from operations remained negative at -$10.351M, though improved from -$20.148M in the prior year.

• · Product revenue increased from $26.487M in Q1 2025 to $191.844M in Q1 2026, while services revenue decreased from $26.771M to $24.849M.
• · Operating income swung from a loss of $20.317M in Q1 2025 to a gain of $29.623M in Q1 2026.
• · Cash used in operating activities improved to -$10.351M from -$20.148M in the prior year.
• · The company repurchased 100,000 Class A units for $1.048M during Q1 2026.
• · Series A preferred units increased from 100,000 to 115,342 units, with proceeds of $15.317M net of issuance costs.
• · Accounts receivable increased to $85.821M from $55.215M, and contract assets increased to $120.701M from $79.680M.
• · Deferred revenue more than doubled to $21.190M from $10.942M.
• · The change in fair value of derivative liability was a loss of $2.4M in Q1 2026, compared to none in Q1 2025.

20-05-2026

Analysis unavailable

20-05-2026

CFN Enterprises Inc. reported net revenues of $87,917 for Q1 2026, a massive increase from $2,283 in Q1 2025, driven primarily by new wine product sales of $83,607. However, the net loss from continuing operations widened to $1,339,334 from $576,148, and total stockholders' deficit deepened to $24,577,098 from $20,393,811 a year earlier, reflecting ongoing financial strain.

• · Net loss per share improved to $(0.15) in Q1 2026 from $(0.31) in Q1 2025.
• · Discontinued operations contributed net income of $60,375 in Q1 2026 versus a net loss of $1,987,462 in Q1 2025.
• · Inventory write-off of $413,250 was recorded in Q1 2026.
• · Accounts payable and accrued liabilities increased to $6,646,299 at March 31, 2026 from $6,353,664 at December 31, 2025.
• · Current liabilities of discontinued operations stood at $13,369,741 at March 31, 2026.
• · Net cash used in operating activities from continuing operations was $227,983 in Q1 2026, compared to $547,354 in Q1 2025.
• · Net cash provided by operating activities from discontinued operations was $109,750 in Q1 2026, down from $619,962 in Q1 2025.
• · The company issued 365,000 shares of common stock for services valued at $409,800 during Q1 2026.
• · Accrued preferred stock interest was $105,000 in Q1 2026, up from $60,000 in Q1 2025.

20-05-2026

Greenway Technologies reported a net loss of $444,132 for Q1 2026, improved from a $683,641 loss in Q1 2025. Operating expenses decreased 44.6% to $294,899, driven by lower G&A and R&D costs. However, the company has an accumulated deficit of $41.8M, negative working capital, and a note in default, raising going concern issues.

• · Working capital deficit of $14,468,915 at March 31, 2026.
• · Stockholders' deficit of $14,468,915 at March 31, 2026.
• · A note for $67,500 is in default as of March 31, 2026.
• · Total accrued interest on a $525,000 note was $366,164 at March 31, 2026.
• · Cash used in operating activities improved to $53,579 in Q1 2026 from $326,307 in Q1 2025.
• · No cash paid for interest in Q1 2026 vs $97,042 in Q1 2025.

20-05-2026

Lifeward Ltd. reported a net loss of $10.8M for Q1 2026, widening from $4.8M in Q1 2025, driven by a 22% revenue decline to $3.9M and a significant increase in R&D expenses to $5.8M (from $0.9M) due to the Oratech acquisition. However, cash and cash equivalents surged to $11.4M from $2.2M at year-end 2025, supported by $6.4M in financing activities and $6.5M from the Oratech acquisition.

• · Net loss per share (basic and diluted) was $6.70 for Q1 2026 vs $5.53 for Q1 2025.
• · Total assets increased to $33.4M as of March 31, 2026 from $22.9M at December 31, 2025.
• · Total liabilities increased to $27.1M from $14.5M, driven by new convertible notes and warrant liabilities.
• · Shareholders' equity decreased to $6.3M from $8.4M.
• · The company issued 1,250,363 ordinary shares in connection with the Oratech transaction.
• · Fair value of warrant liabilities and derivative liabilities totaled $10.0M as of March 31, 2026.
• · The company had an accumulated deficit of $295.5M as of March 31, 2026.

20-05-2026

ASP Isotopes Inc. reported Q1 2026 total revenue of $4,180,000, up from $1,102,000 in Q1 2025, driven by product revenue of $3,980,000 and collaboration revenue of $200,000. Gross profit improved to $1,666,000 from $327,000. However, operating expenses surged to $26,554,000 from $8,279,000, leading to a net loss from continuing operations of $26,706,000 compared to $8,461,000 in the prior year. The company recorded $19,585,000 in income from discontinued operations, resulting in a net loss attributable to shareholders of $6,878,000, an improvement from $8,446,000. Cash and cash equivalents decreased to $207,346,000 from $279,572,000 at year-end 2025.

• · Research and development expenses increased to $5,263,000 in Q1 2026 from $1,530,000 in Q1 2025.
• · Selling, general and administrative expenses rose to $21,291,000 from $6,749,000 year-over-year.
• · Interest income was $3,047,000 in Q1 2026 compared to $513,000 in Q1 2025.
• · Interest expense increased to $1,729,000 from $87,000.
• · Foreign exchange transaction loss was $3,725,000 versus $61,000 in the prior year.
• · Net cash used in operating activities from continuing operations was $16,639,000, up from $3,170,000.
• · Net cash used in investing activities from continuing operations was $97,183,000, compared to $2,359,000.
• · Cash provided by financing activities from discontinued operations was $45,886,000.
• · The company issued 14,270,000 shares of common stock to acquire Renergen.
• · Noncontrolling interests decreased to $10,016,000 from $58,747,000, primarily due to deconsolidation of a subsidiary.
• · Current debt surged to $53,265,000 from $584,000, reflecting new borrowings.
• · Natural gas properties of $130,222,000 were added during the quarter.
• · Equity method investments of $24,855,000 and other investments of $15,580,000 were recorded.
• · Goodwill increased to $6,394,000 from $5,177,000.

20-05-2026

Heritage Distilling reported Q1 2026 total net revenue of $1.71M, up 57% from $1.09M in Q1 2025, driven by new crypto and related revenue of $1.45M. However, spirits products revenue declined 71% to $0.25M, and the company recorded a massive net loss of $66.7M vs. $3.0M in the prior year, primarily due to a $62.1M non-cash impairment on intangible digital assets. Total assets fell from $108.8M to $42.8M, and accumulated deficit widened to $278.6M.

• · Gross profit improved to $1.17M in Q1 2026 from $0.27M in Q1 2025, driven by crypto revenue with low cost of revenue.
• · Operating expenses surged to $67.6M from $2.7M, primarily due to $62.1M impairment on intangible digital assets.
• · Cash used in operating activities was $2.45M in Q1 2026 vs $2.03M in Q1 2025.
• · Investing activities provided $2.31M in Q1 2026 from sale of intangible digital assets, vs $0.07M in Q1 2025.
• · Financing activities used $0.01M in Q1 2026 vs providing $1.61M in Q1 2025.
• · Intangible digital assets decreased from $91.7M to $24.8M due to impairment and sales.
• · Digital assets receivable of $1.48M appeared as a new current asset in Q1 2026.
• · Total liabilities decreased slightly to $10.36M from $10.54M.
• · Stockholders' equity dropped from $98.2M to $32.4M due to the large net loss.
• · Weighted average shares outstanding (basic) increased from 24,056 to 496,228 due to reverse split and equity issuances.

20-05-2026

Vivakor, Inc. reported a net loss of $4.58M for Q1 2026, improving from a $7.53M loss in Q1 2025. Total revenues decreased 47.9% YoY to $19.46M, while gross profit increased 20.3% to $5.72M. Cash and restricted cash fell sharply to $75k from $2.10M at year-end 2025, and the company had an accumulated deficit of $211.05M.

• · Accounts receivable net decreased to $2.20M from $3.53M, while related party receivables increased to $5.95M from $1.44M.
• · Allowance for credit losses on accounts receivable was $1.51M at March 31, 2026, compared to $0 at December 31, 2025.
• · Property and equipment net decreased to $57.14M from $58.30M, with $12.37M in construction in process.
• · Intangible assets net decreased to $7.32M from $7.52M.
• · Total current liabilities increased to $62.96M from $61.52M.
• · Net cash used in operating activities was $3.32M in Q1 2026, compared to essentially zero in Q1 2025.
• · No cash was paid for interest in Q1 2026, versus $218k in Q1 2025.
• · Basic and diluted net loss per share improved to $(2.32) from $(42.32) due to increased share count.
• · Weighted average common shares outstanding increased to 2,919,188 from 215,384.
• · Series A Preferred Stockholder Dividends of $2.20M were declared in Q1 2026, up from $1.59M in Q1 2025.